References
- Hu HY, Wu CY, Huang N, Chou YJ, Chang YC, Chu D. Increased risk of tuberculosis in patients with end-stage renal disease: A population-based cohort study in Taiwan, a country of high incidence of end-stage renal disease. Epidemiol Infect. 2014;142:191–199.
- Lightstone L. Preventing renal disease: The ethnic challenge in the United Kingdom. Kidney Int Suppl. 2003;63:S135–S138.
- Ulasli SS, Ulubay G, Arslan NG, et al. Characteristics and outcomes of end-stage renal disease patients with active tuberculosis followed in intensive care units. Saudi J Kidney Dis Transpl. 2009;20:254–259.
- Yuan FH, Guang LX, Zhao SJ. Clinical comparisons of 1,498 chronic renal failure patients with and without tuberculosis. Ren Fail. 2005;27:149–153.
- Quantrill SJ, Woodhead MA, Bell CE, Hardy CC, Hutchison AJ, Gokal R. Side effects of antituberculosis drug treatment in patients with chronic renal failure. Eur Respir J. 2002;20:440–443.
- The National Collaborating Centre for Chronic Conditions. Tuberculosis: Clinical Diagnosis and Management of Tuberculosis and Measures for its Prevention and Control. London: Royal College of Physicians; 2006. Updated 2011.
- Lichtenstein IH, MacGregor RR. Mycobacterial infections in renal transplant recipients: Report of five cases and review of the literature. Rev Infect Dis. 1983;5:216–226.
- Public Health England. Tuberculosis in the UK: 2014 Report. London: Health Protection Agency; 2014. Available at: https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/360335/TB_Annual_report__4_0_300914.pdf. Accessed November 10, 2014.
- Moore DA, Lightstone L, Javid B, Friedland JS. High rates of tuberculosis in end-stage renal failure: The impact of international migration. Emerg Infect. Dis. 2002;8:77–78.
- British Thoracic Society Standards of Care Committee and Joint Tuberculosis Committee, Milburn HJ, Ashman N, et al. For the BTS Standards of Care Committee. Guidelines for the prevention and management of Mycobacterium tuberculosis infection and disease in adult patients with chronic kidney disease. Thorax 2010;65:559–570.
- Karadag P, Gursu M, Ozturk S, et al. Prevalence of tuberculosis in patients on hemodialysis and peritoneal dialysis. J Infect Dis Immun. 2011;3:189–192.
- Shu CC, Wu VC, Yang FJ, et al. Predictors and prevalence of latent tuberculosis infection in patients receiving long-term hemodialysis and peritoneal dialysis. PLoS One 2012;7:e42592.
- Sita-Lumsden A, Lapthorn G, Swaminathan R, Milburn HJ. Reactivation of tuberculosis and vitamin D deficiency: The contribution of diet and exposure to sunlight. Thorax 2007;62:1003–1007.
- Martineau AR, Wilkinson RJ, Wilkinson KA, et al. A single dose of vitamin D enhances immunity to mycobacteria. Am J Respir Crit Care Med. 2007;176:208–213.
- Chan TY. Vitamin D deficiency and susceptibility to tuberculosis. Calcif Tissue Int. 2000;66:476–478.
- Health Protection Agency Centre for Infections. Tuberculosis in the UK: Annual Report on Tuberculosis Surveillance in the UK 2010. London: Health Protection Agency; 2010. Available at: http://webarchive.nationalarchives.gov.uk/20140629102627/http://www.hpa.org.uk/webc/HPAwebFile/HPAweb_C/1287143594275. Accessed November 4, 2014.
- Health Protection Agency London Press Releases. HIV Prevalence Greatest in London Boroughs but Quality of Care is High. London: Health Protection Agency; 2010. Available at: http://www.hpa.org.uk/ProductsServices/LocalServices/London/LondonPressReleases/Lond101126HIVprevalencegreatestinLondon. Accessed November 4, 2014.
- Venkata RK, Kumar S, Krishna RP, Kumar SB, Padmanabhan S, Kumar S. Tuberculosis in chronic kidney disease. Clin Nephrol. 2007;67:217–220.
- Hussein M, Mooji J, Roujouleh H. Tuberculosis in hemodialysis patients. Saudi J Kidney Dis Transpl. 1996;7:6–9.
- Nakamura H, Tateyama M, Tasato D, et al. Active tuberculosis in patients undergoing hemodialysis for end-stage renal disease: A 9-year retrospective analysis in a single center. Intern Med. 2009;48:2061–2067.
- García-Leoni ME, Martín-Scapa C, Rodeño P, Valderrábano F, Moreno S, Bouza E. High incidence of tuberculosis in renal patients. Eur J Clin Microbiol Infect Dis. 1990;9: 283–285.
- Chuang FR, Lee CH, Wang IK, Chen JB, Wu MS. Extrapulmonary tuberculosis in chronic hemodialysis patients. Ren Fail. 2003;25:739–746.
- Ates G, Yildiz T, Danis R, et al. Incidence of tuberculosis disease and latent tuberculosis infection in patients with end stage renal disease in an endemic region. Ren Fail. 2010;32:91–95.
- Nachega JB, Chaisson RE. Tuberculosis drug resistance: A global threat. Clin Infect Dis. 2003;36(Suppl. 1):S24–S30.
- Queensland Tuberculosis Control Centre Guidelines for Treatment of Tuberculosis in Patients with Renal Disease. Queensland Tuberculosis Control Centre. 2007. Available at: https://www.health.qld.gov.au/publications/clinical-practice/guidelines-procedures/diseases-infection/governance/tb-guideline-renal.pdf (accessed December 2015).
- American Thoracic Society; CDC; Infectious Diseases Society of America. Treatment of tuberculosis. MMWR Recomm Rep. 2003;52:1–77.
- Segall L, Covic A. Diagnosis of tuberculosis in dialysis patients: Current strategy. Clin J Am Soc Nephrol. 2010;5:1114–1122.
- Sester M, van Leith F, Bruchfield J, et al. Risk assessment of tuberculosis in immunocompromised patients. A TBNET study. Am J Respir Crit Care Med. 2014;190: 1168–1176.